Needham Investment Management’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-40,000
Closed -$5.47M 96
2018
Q2
$5.47M Sell
40,000
-17,500
-30% -$1.59M 1.53% 23
2018
Q1
$4.53M Hold
57,500
1.29% 26
2017
Q4
$3.92M Hold
57,500
1.04% 33
2017
Q3
$2.31M Hold
57,500
0.59% 49
2017
Q2
$2.29M Hold
57,500
0.61% 46
2017
Q1
$1.85M Hold
57,500
0.48% 50
2016
Q4
$1.02M Hold
57,500
0.26% 65
2016
Q3
$1.34M Hold
57,500
0.35% 52
2016
Q2
$1.07M Sell
57,500
-10,000
-15% -$181K 0.3% 58
2016
Q1
$1.23M Buy
67,500
+7,500
+13% +$121K 0.32% 56
2015
Q4
$1.26M Hold
60,000
0.31% 57
2015
Q3
$1.11M Hold
60,000
0.28% 61
2015
Q2
$2.03M Buy
+60,000
New +$2.41M 0.44% 54

Needham Investment Management's FMI Position: Q3 2018 in Review

Needham Investment Management sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 40,000 shares — an estimated $5.47M sold.

Needham Investment Management first reported a position in FMI in Q2 2015 and held it in 13 quarters. The position peaked at $5.47M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Needham Investment Management reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Needham Investment Management sold 40,000 Foundation Medicine, Inc. shares in Q3 2018, an estimated $5.47M.
  • Needham Investment Management first reported a position in Foundation Medicine, Inc. in Q2 2015 and held it in 13 quarters.
  • Needham Investment Management's Foundation Medicine, Inc. position peaked at $5.47M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Needham Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.